您的位置: 首页 > 农业专利 > 详情页

Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
专利权人:
ANTHROGENESIS CORPORATION
发明人:
ZHANG XIAOKUI,VOSKINARIAN-BERSE VANESSA A.,KANG LIN,PADLIYA NEERAV DILIP,HEIDARAN MOHAMMAD A.,PAL AJAI,ZEITLIN ANDREW,HARIRI ROBERT J
申请号:
NZ59982508
公开号:
NZ599825A
申请日:
2008.09.29
申请国别(地区):
NZ
年份:
2014
代理人:
摘要:
Discloses the use of human placental perfusate cells in the manufacture of a medicament for suppressing the proliferation of blood cancer cells, wherein the placental perfusate cells are (a) total nucleated cells from placental perfusate, (b) placental perfusate cells that have been treated to remove at least one type of cell, or (c) placental perfusate cells that have been treated to enrich for at least one type of cell. and wherein the placental perfusate cells are contacted with an immunomodulatory compound to exhibit detectable more cytotoxicity towards solid tumor cells than an equivalent number of perfusate cells that have not been contacted with an immunomodulatory compound.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充